We further validated the expression levels of GSDME, GPX4, and SCAF11 in a mouse HCC model, which was constructed by knocking out the p53 and overexpressing the myc in the mouse liver (Figure 10A). This evidence concerns the gene TP53 and hepatocellular carcinoma.